These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 220844)

  • 1. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
    Georgiev VP; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover].
    Bernasconi R; Steulet AF; Aryee D; Martin P; Leonhardt T; Bischoff S; Maitre L
    Encephale; 1989; 15(4):377-85. PubMed ID: 2572414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V
    Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
    Bartholini G; Scatton B; Zivkovic B
    Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of various new GABAergics on motor and oral stereotypes with apomorphine in the rat].
    Vamvakidès A; Kassianidès A; Papadopoulou-Daifoti Z
    J Pharmacol; 1985; 16(4):403-11. PubMed ID: 4094437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
    Sethy VH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
    Costentin J
    Encephale; 1979; 5(2):121-49. PubMed ID: 38958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of 2 new GABA-ergic agents on apomorphine stereotypy in the rat].
    Vamvakidès A
    Agressologie; 1985 Jan; 26(1):63-5. PubMed ID: 4041140
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic and GABAergic mediations of the effects of apomorphine on serotonin neurons.
    Chen HY; Lin YP; Lee EH
    Synapse; 1992 Jan; 10(1):34-43. PubMed ID: 1371366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement.
    Kendall DA; Browner M; Enna SJ
    J Pharmacol Exp Ther; 1982 Mar; 220(3):482-7. PubMed ID: 7062260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
    Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.